Xenon Pharmaceuticals Inc
NASDAQ:XENE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
X
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
CA |
|
EACO Corp
OTC:EACO
|
US |
Intrinsic Value
The intrinsic value of Xenon Pharmaceuticals Inc (XENE) under the Base Case is 20.84 USD per share. Compared with the current market price of 36.5 USD, the stock appears Overvalued by 43% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Xenon Pharmaceuticals Does
Xenon Pharmaceuticals is a biotechnology company that designs and develops medicines for neurological diseases. Its main focus is on drugs that act on ion channels, which are proteins that help control how nerve cells send signals. The company’s pipeline targets conditions such as epilepsy and other brain and nervous system disorders.
- Headquarters
- Canada CA
- Employees
- 358
- IPO date
- Oct 17, 2014
Revenue & Expenses Breakdown
Xenon Pharmaceuticals Inc
Earnings Waterfall
Xenon Pharmaceuticals Inc
The intrinsic value for Xenon Pharmaceuticals Inc (XENE) under the Base Case is 20.84 USD.
Compared with the current market price of 36.5 USD, the stock appears Overvalued by 43% .